Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Acceptability, and Preliminary Effects of e-Perinatal Butterfly, an Embedded Digital Intervention for Parents Experiencing Perinatal Loss

NCT07898176 is registered in ClinicalTrials.gov with University of Seville as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07898176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Acceptability, and Preliminary Effects of e-Perinatal Butterfly, an Embedded Digital Intervention for Parents Experiencing Perinatal Loss
Lead sponsor
University of Seville
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 12, 2027
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety symptoms, depressive symptoms, perinatal grief, perinatal loss

Arms

As registered; 2 arms.

  • Intervention group Experimentale-Perinatal Butterfly
  • Control group Active comparatorStandard routine maternal care

Primary endpoints

Registered primary outcome measures; 3 primary.

  • Feasibility of the intervention Measured at enrollment and postintervention (3 months after enrollment)

    Calculation of participation rate, recruitment rate, and retention rate (follow-up rate) at all assessment points. Assessment method: Registration and follow-up records.

  • Early acceptability Measured at enrollment

    Number of eligible women and partners who agree to participate. Assessment method: Login to e-Perinatal Butterfly.

  • Final acceptability Measured at postintervention (3 months after enrollment)

    Evaluation of how appropriate, satisfactory, and feasible the intervention is after its implementation. Assessment method: Surveys and semi-structured interviews based on the Normalization Process Theory.

Lead sponsor's other trials

University of Seville, most recent start first.

Similar trials

Same condition (Perinatal Death) and phase, most recent start first.